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Abstract
Magmas is a growth factor responsive gene encoding an essential mitochondrial protein in mammalian cells. Pam16, the
Magmas ortholog in Saccharomyces cerevisiae, is a component of the presequence translocase-associated motor. A
temperature-sensitive allele (pam16-I61N) was used to query an array of non-essential gene-deletion strains for synthetic
genetic interactions. The pam16-I61N mutation at ambient temperature caused synthetic lethal or sick phenotypes with
genes involved in lipid metabolism, perixosome synthesis, histone deacetylation and mitochondrial protein import. The
gene deletion array was also screened for suppressors of the pam16-I61N growth defect to identify compensatory pathways.
Five suppressor genes were identified (SUR4, ISC1, IPT1, SKN1, and FEN1) and all are involved in sphingolipid metabolism.
pam16-I61N cells cultured in glucose at non-permissive temperatures resulted in rapid growth inhibition and G1 cell cycle
arrest, but cell viability was maintained. Altered mitochondria morphology, reduced peroxisome induction in glycerol/
ethanol and oleate, and changes in the levels of several sphingolipids including C18 alpha-hydroxy-phytoceramide, were
also observed in the temperature sensitive strain. Deletion of SUR4, the strongest suppressor, reversed the temperature
sensitive fermentative growth defect, the morphological changes and the elevated levels of C18 alpha-hydroxy
phytoceramide in pam16-I61N. Deletion of the other four suppressor genes had similar effects on C18 alpha-hydroxy-
phytoceramide levels and restored proliferation to the pam16-I61N strain. In addition, pam16-I61N inhibited respiratory
growth, likely by reducing cardiolipin, which is essential for mitochondrial function. Our results suggest that the pleiotropic
effects caused by impaired Pam16/Magmas function are mediated in part by changes in lipid metabolism.
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Introduction
Mitochondrial associated granulocyte macrophage signaling
molecule (Magmas) is a nuclear encoded protein found in the
mitochondrial matrix of mammalian cells. It was identified as a
transcript that is rapidly induced in the multipotential myeloid cell
line PGMD1 by granulocyte-macrophage colony-stimulating
factor (GM-CSF) [1]. Magmas is highly conserved [2] and is
essential for survival in eukaryotic cells [3,4,5]. In addition to the
mitochondrial targeting domain [1] a comparison of Magmas
homologs from 52 species distributed among animals, plants and
fungi revealed three conserved sequence motifs [2]. Kingdom
specific amino acid signatures, the potential targeting of the
protein to locations other than the mitochondria, and the presence
of multiple isoforms in higher eukaryotes suggest that Magmas
may function in multiple contexts [2].
Magmas is variably expressed and protein levels are develop-
mentally regulated in mammalian cells [1,6]. During murine
embryogenesis, the highest levels of Magmas are observed in
heart, notochord, choroid plexus, cervical ganglion, nasal mucosa
and liver. Adult tissues with high Magmas expression include
muscle, pancreas, intestinal mucosa, and testes [6].
Magmas expression also differs in normal and neoplastic
prostate [7]. The protein is barely detectable in normal prostate
glands but increased amounts are observed in some higher-grade
tumors. The increased Magmas in malignant cells results from
higher amounts of Magmas/cell and not from changes in the
number of mitochondria/cell [7]. Investigations in breast cancer
correlate increased Magmas expression to poor outcome [8,9],
while studies in pituitary adenoma and Burkitt’s lymphoma cells
suggest that increased Magmas levels protect against apoptosis
[10,11]. These data suggest that Magmas has an important role in
human cancers.
Human Magmas and its yeast ortholog, Pam 16, are 42%
identical and exhibit functional conservation. Expression of
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human Magmas in yeast fully complements the lethal phenotype
of PAM16 null cells [12,13] and validates the use of yeast as a
model system to study the fundamental properties of the human
protein. Pam16 is a regulatory component of the presequence
translocase-associated motor (PAM), which is responsible for the
transport of proteins into the mitochondrial matrix [14,15,16].
Pam16 binding to Pam18 results in recruitment and stabiliza-
tion of Pam18 to the TIM23 translocase complex, located in
the inner mitochondrial membrane. These interactions stimulate
the ATPase activity of Ssc1 (the yeast homolog of Hsp70) which
produces the driving force responsible for the translocation of
proteins into the mitochondrial matrix [12,13,16,17,18,19,20].
To better understand Magmas function we conducted genetic
and functional studies on PAM16. A temperature sensitive PAM16
mutation (I61N) was used to identify synthetic sick and lethal (SSL)
genetic interactions of PAM16. In addition to genetic interactions
that support the role of Pam16 in mitochondrial protein import,
novel interactions of PAM16 were identified suggesting its
involvement in other functions including lipid metabolism and
transcription. Genetic screening also identified gene deletions that
suppressed the pam16-I61N ts proliferation defect. SUR4, encoding
a fatty acid elongase involved in sphingolipid biosynthesis [21,22],
was the most effective suppressor. Strains containing pam16-I61N
with or without a deletion of SUR4 were additionally characterized
by proliferation studies, cell cycle analysis, morphology, and
sphingolipid profiles. Our results suggest that the deleterious
effects of impaired PAM16/Magmas activity are mediated in part
through changes in sphingolipid metabolites.
Results
A Temperature-sensitive PAM16 Mutant Exhibits Defects
in Fermentation and Respiration
Microscopic examination of spores dissected from PAM16
heterozygous null asci revealed two normal colonies and two single
cells (data not shown) demonstrating that haploid null spores are
unable to undergo a single cell division and confirming that
PAM16 is essential for proliferation. Thus to characterize the
functional roles of Magmas, conditional alleles of PAM16 were
necessary. Temperature sensitive alleles were created by random
mutagenesis and screened for their inability to grow at elevated
temperatures. Four unique mutant strains that displayed impaired
growth at 37uC on glucose and on glycerol/ethanol media (YPGE)
contained only a single amino acid substitution. The strain that
grew best at 30uC but that did not grow at 37uC had a change at
amino acid 61 from isoleucine to asparagine (I61N). This amino
acid is identical in Pam16 and Magmas and is located within a
sequence of high homology (EX3IL) conserved across fungi, plants
and animals [2]. Pam16-I61N cells incubated for 7 days on YEPD
at 37uC remained fully viable and when cultured at 30uC the same
numbers of colonies were obtained as on duplicate plates grown at
30uC for 3 days (data not shown).
The temperature dependent growth of the pam16-I61N strain on
fermentable (glucose) or non-fermentable (glycerol/ethanol) car-
bon sources is shown in Figure S1. The pam16-I61N strain
exhibited a strong ts phenotype on both media although the
temperature required to completely inhibit growth was lower on
glycerol/ethanol. Since the pam16-I61N mutation affects fermen-
tative growth in addition to respiratory metabolism, it appears that
Pam16 may affect metabolic pathways outside of the mitochon-
drial matrix.
Synthetic Genetic Interactions
The pam16-I61N mutation was introduced into the Y7092 strain
(Table 1) to serve as a query strain for SGA analysis. A control
strain (Y8835) was screened in parallel and pam16-I61N xxxD
double mutant colonies were identified that failed to grow as well
as pam16-I61N at 30uC and 32uC. pam16-I61N xxxD colonies were
also incubated at the restrictive temperature of 34uC to identify
gene-deletions that suppress the loss of PAM16 function. Sixty
candidate synthetic genetic interactions were initially identified
using automated image analysis and visual inspection. Forty-six of
these were verified as synthetic sick or lethal (SSL) interactions by
random spore analysis (Table 2).
Fourteen of the 46 SSL partners had a petite phenotype in the
original gene-deletion array but were more severely growth
impaired in the double mutant (Table 2). Petite strains do not
have respiration competent mitochondria. Since only 227 of the
4285 gene-deletion array strains have a ‘‘respiratory growth
absent’’ phenotype [23], the 5.7-fold enrichment for this
phenotype in our screen (p,0.01) supports the role of PAM16/
Magmas in specific interactions with genes involved in the
regulation of oxidative metabolism [13,24].
Figure S2 shows an interaction network of all the PAM16 SSL
genes depicted as nodes colored according to gene ontology (GO)
biological process designations [25] and edges representing known
physical or genetic interactions. When the genes were categorized
according to biological function, four major groups were apparent:
mitochondrial lipid metabolism, histone modification, mitochon-
drial protein import, and peroxisome biogenesis and glycolysis
(Figure 1). These groups served as the basis for further analysis of
Pam16 function.
Mitochondrial Lipid Metabolism
The functional group containing the largest number of
interacting genes established a synthetic relationship between
Table 1. Saccharomyces cerevisiae strains.
Strain Genotype Reference
orfDarray MATa orfD::KanMX4 his3D leu2D met15D ura3D [4]
Y8835 MATa can1D::STE2pr-his5 lyp1D ura3D::natR leu2D0 his3D1 met15D0 [87]
Y7092 MATa can1D::STE2pr-his5 lyp1D ura3D0 leu2D0 his3D1 met15D0 [87]
pam16-I61N MATa pam16-I61N::NatR, can1D::MFA1-prHIS3 MFa1pr-LEU2 leu2D0 his3D1 This study
sur4D MATa sur4D:::NatR, can1::MFA1-prHIS3 MFa1pr-LEU2 leu2D0 his3D1 This study
pam16-I61N sur4D MATa pam16-I61N::NatR, sur4D::URA3, can1 ::MFA1-prHIS3 MFa1pr-LEU2 leu2D0 his3D1 This study
W303 MATa leu2-3, 112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15 [85]
doi:10.1371/journal.pone.0039428.t001
Pam16 and Sphingolipid Metabolism
PLoS ONE | www.plosone.org 2 July 2012 | Volume 7 | Issue 7 | e39428
PAM16 and 12 genes involved in mitochondrial lipid metabolism
(Figure 1, blue nodes and Table 2). Ten of these genes encode
proteins that are located in the mitochondrial matrix (Table 2) and
are involved in mitochondrial specific fatty acid synthesis and the
lipoylation of proteins [26,27,28]. The two other genes, CRD1 and
TAZ1, are essential for the biosynthesis of cardiolipin in the
mitochondrial inner membrane. Cardiolipin is important for
maintaining mitochondrial membrane potential [29], vacuolar
homeostasis [30,31] and stabilizing respiratory chain complexes
[32].
Histone Modification
The second most numerous SSL gene set includes 7 genes
involved in histone modification (Figure 1, green nodes and
Table 2). Five of these genes are involved in the Rpd3L histone
deacetylase complex, which regulates transcription at distinct
promoter regions [33,34]. Rpd3L negatively regulates genes
encoding mitochondrial proteins and proteins involved in meiosis
and metabolism. The positively regulated genes are involved in
heat shock, osmotic stress and fermentative growth [35,36]. All the
genes in the histone modification group have hundreds of physical
and genetic interactions (Saccharomyces Genome Database)
besides those shown in the pam16-I61N SSL partner set (Figure
S2, inner circle). These seven genetic interactions associated with
histone modification have not been previously linked to PAM16.
Mitochondrial Protein Import
A third functional cluster consists of genes involved in
mitochondrial protein import. Pam16 is a constituent of the
presequence translocase-associated motor (PAM) complex. Six
genes from the mitochondrial membrane protein import system
resulted in significantly impaired growth with pam16-I61N
(Figure 1, red nodes and Table 2). MMM1, TOM37, and
TOM70 are mitochondrial outer membrane proteins involved in
protein import and additionally have a role in phospholipid
biosynthesis and calcium exchange [37,38,39]. PHB2, YME1, and
FMP18 are associated with the mitochondrial inner membrane.
Phb2 [40] is a subunit of the prohibitin complex, a chaperone for
newly synthesized proteins [41]. YME1 codes for the catalytic
subunit of the mitochondrial inner membrane i-AAA protease
complex, which degrades misfolded proteins in the mitochondrial
inner membrane and matrix [42,43]. Of the six genes in this group
only Fmp18 (Pam17) has been reported to physically interact with
Pam16 [44]. Twenty-two of the 46 SSL partners of pam16-I61N
were not common to any of the genetic or physical interactions
previously identified for the other genes/proteins involved in
mitochondrial protein import (data not shown) [23]. This supports
our findings that Pam16 is involved in several biological functions.
Peroxisome Biogenesis and Glycolysis
Negative synthetic interactions were also observed with genes
encoding integral membrane proteins of the peroxisome, an
organelle responsible for production of fatty acids and energy
intermediates during degradation of complex lipids (Figure 1,
yellow nodes and Table 2). PEX29 and PEX30 are genes required
Table 2. pam16-I61N synthetic sick or lethal partners.
Gene name
Systemic
name SSLa petite Functional groupb
CRD1 ydl142c +++ Mitochondrial Lipid Metabolism
ETR1 * ybr026c ++ X Mitochondrial Lipid Metabolism
HFA1 * ymr207c +++ Mitochondrial Lipid Metabolism
LAT1 * ynl071w +++ Mitochondrial Lipid Metabolism
LIP2 * ylr239c + X Mitochondrial Lipid Metabolism
LIP5 * yor196c +++ X Mitochondrial Lipid Metabolism
LPD1 * yfl018c + X Mitochondrial Lipid Metabolism
MCT1 * yor221c +++ X Mitochondrial Lipid Metabolism
PDA1 * yer178w +++ Mitochondrial Lipid Metabolism
PDB1 ybr221c ++ Mitochondrial Lipid Metabolism
RPM2 yml090wc +++ X Mitochondrial Lipid Metabolism
TAZ1 * ypr140w + Mitochondrial Lipid Metabolism
BRE1 ydl074c +++ Histone Modification
DEP1 yal013w ++ X Histone Modification
LGE1 ypl055c +++ Histone Modification
PHO23 ynl097c +++ Histone Modification
RXT2 ybr095c ++ Histone Modification
SAP30 ymr263w ++ Histone Modification
SIN3 yol004w +++ X Histone Modification
FMP18 ykr065c +++ Mitochondrial Protein Import
MMM1 * yll006w +++ X Mitochondrial Protein Import
PHB2 ygr231c +++ Mitochondrial Protein Import
TOM37 * ymr060c +++ Mitochondrial Protein Import
TOM70 ynl121c +++ Mitochondrial Protein Import
YME1 ypr024w +++ X Mitochondrial Protein Import
PEX29 ydr479c +++ Peroxisomal b-oxidation
PEX30 ylr324w +++ Peroxisomal b-oxidation
PFK2 ? ymr205c + Cytoplasm (Glycolysis)
ATP11 * ynl315c +++ X Mitochondrial Matrix
CAF40 * ynl288w +++ Cytoplasm
CDC73 * ylr418c +++ Nucleus
CTK1 * ykl139w +++ Cytoplasm And Nucleus
DBF2 * ygr092w +++ Cytoplasm &Bud Neck
GCR2 * ynl199cd +++ Nucleus
KAR3 * ypr141c +++ Microtubule, Spindle Pole Body
MCK1 * ynl307c + Cytoplasm and Nucleus
MDL2 * ypl270w ++ X Mitochondrion Inner Membrane
MRT1 * ycr077c +++ Cytoplasm
RPL19B * ybl027w + Cytosolic Large Ribosomal Subunit
RVS167 * ydr388w ++ X Actin Cortical Patch, Cytoplasm
SWS2 * ynl081c + X Mitochondrial Small Ribosome
THR1 * yhr025w ++ Amino Acid Biosynthesis
YBR238C ybr238c +++ Mitochondrion
YDR290W ydr290w + Unknown
YJR120W * yjr120w +++ Unknown
YHL039W yhl039w ++ Cytoplasm
*: synthetic sick or lethal interaction suppressed by additional deletion of SUR4.
aSeverity of SSL defect from low+ to high+++.
bFunctional group from Figure 1 or GO cellular component or process.
cThe interaction with YML090W, a dubious open reading frame, was replaced by
RPM2, an essential gene on the opposite DNA strand whose transcription is
inhibited but not eliminated by the YML090W deletion (data not shown).
dThe interaction with GRC2 was further confirmed by deletion of YNL198c, an
overlapping dubious open reading frame on the opposite DNA strand.
doi:10.1371/journal.pone.0039428.t002
Table 2. Cont.
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for regulating peroxisome size, number and distribution [45,46].
PFK2 encodes phosphofructokinase a major glycolytic enzyme.
Genetic Suppressors of pam16-I61N are Involved in
Sphingolipid Metabolism
Five gene deletions (SUR4, ISC1, IPT1, SKN1, and FEN1) were
identified as suppressors of the temperature-sensitive phenotype of
pam16-I61N at 34uC. All of these genes are involved in
sphingolipid metabolism. SUR4 encodes an elongase that synthe-
sizes very long chain 20–26-carbon fatty acids from C18-CoA
primers and is involved in sphingolipid biosynthesis [21]. The
Fen1 elongase has a similar role, with a maximum fatty acid chain
length of 24 carbons [22]. Isc1 (inositol phosphosphingolipid
phospholipase C) hydrolyzes complex phosphorylceramides to
produce alpha-hydroxy-phytoceramides and polar headgroups
[47,48]. Deletion of ISC1 causes defects in mitochondrial function
and failure to up-regulate genes involved in aerobic metabolism
after the diauxic shift [49,50].
Ipt1 (inositolphosphotransferase) and Skn1 (a putative glucosyl-
transferase) are both involved in the synthesis of mannose-(inositol-
P)2-ceramide (M(IP)2C), the most abundant complex sphingolipid
in yeast [51,52]. Skn1 and Ipt1 can complement each other in
M(IP)2C synthesis under limited nutrients whereas skn1D ipt1D
strains show increased autophagy and DNA fragmentation [53].
Deletion of FEN1, IPT1 or SKN1 suppressed the 34uC ts
phenotype of pam16-I61N although not as well as deletion of
ISC1 or SUR4. Of the five suppressor strains, the pam16-I61N
sur4D strain showed the strongest growth phenotype and was
chosen for further analysis. Notably, the suppressor phenotype
requires a partially functional pam16 allele since it cannot suppress
the lethality of a PAM16 deletion (data not shown).
Synthetic Genetic Interactions of a pam16-I61N sur4D
Double Mutant Query Strain
To understand the functional relationship between sur4D
suppression of pam16-I61N and the SSL interactions with pam16-
I61N we screened the deletion array using a pam16-I61N sur4D
double mutant query strain (Table 2). Nineteen of 46 SSL partners
of pam16-I61N retained their SSL phenotype while the remaining
27 SSL interactions were suppressed by the deletion of SUR4. The
sur4D suppression phenotypes can be divided along functional
lines. No SSL interactions in the histone modification group were
suppressed. Most SSL interactions with mitochondrial protein
import genes were also not suppressed. However, two genes in this
group (TOM37 and MMM1) associated with the outer mitochon-
drial membrane were no longer SSL with pam16-I61N when SUR4
was deleted. Similarly, 9 of 12 SSL interactions of pam16-I61N
with the mitochondrial lipid metabolism genes were suppressed by
deletion of SUR4. The genes in this group that remained SSL were
CRD1, PDB1 and RPM2.
Growth Characterization of Wild Type, pam16-I61N, sur4D
and the pam16-I61N sur4D Strains
The growth of wild type (wt), pam16-I61N, sur4D and pam16-
I61N sur4D strains was evaluated at the three temperatures used in
the SGA screens. Growth curves in YEPD media show the typical
rapid initial rise in cell density (characteristic of fermentative
growth) until the depletion of glucose results in the switch to
respiratory metabolism (diauxic shift) and slower growth prior to
entry into stationary phase [54,55] (Figure 2A–C). The fermen-
tative doubling time for the strains at each temperature is shown in
Figure 2D. The wt, pam16-I61N, sur4D and the pam16-I61N sur4D
strains all grew at 30uC in glucose although the growth rate of the
mutant strains was slower than wt cells.
The reduced ability of pam16-I61N to grow on glucose at 32uC
and inability to grow at 34uC was partially corrected to wt levels
by the deletion of SUR4 (Figure 2B–D, and Figure 3, top four
rows). This data is in agreement with the SGA screen, which
showed that proliferation of pam16I61N in glucose containing
media was restored at 34uC by deletion of SUR4. The sur4D
suppression of the pam16-I61N growth defect in media containing
glucose similarly occurs in rho0 strains, which lack functional
Figure 1. Synthetic lethal partners of pam16-I61N. 28 of the 46 SSL partners of pam16-I61N were grouped into 4 major biological functions.
They are mitochondrial protein import (red), histone modification (green), mitochondrial lipid metabolism (blue), and peroxisome biogenesis and
glycolysis (yellow). Genes that are functionally related radiate from a central point.
doi:10.1371/journal.pone.0039428.g001
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mitochondria (Figure S3). The rho0 results suggest that Pam16
provides an essential activity during fermentative growth that is
independent of its role in the presequence translocase and other
mitochondrial functions.
No growth was observed in pam16-I61N after the diauxic shift at
32uC and 34uC (Figure 2B,C; blue line). At 30uC the pam16-I61N
grew slower than the wt strain and sur4D strains. In contrast to all
the other strains pam16-I61N sur4D was unable to proliferate at
30uC following the diauxic shift (Figure 2A; red line). This
demonstrates that deletion of SUR4 increases the severity of the
respiratory growth defect in the pam16-I61N strain.
In addition to very long chain fatty acids, the synthesis of
sphingolipids requires a long chain base (LCB) and a polar head
group. LCB synthesis is normally required for viability [56] and
thus the potential functional relationship between LCBs and
pam16-I61N was not assessed by screening the deletion array. We
therefore examined whether sur4D suppression of pam16-I61N
could be phenocopied by pharmacological reduction of LCB
synthesis using myriocin, an inhibitor of serine palmitoyltransfer-
ase [57]. Myriocin at 400 ng/ml slowed the growth of all strains
consistent with the global inhibition of LCB synthesis (Figure 3).
However, neither this dose of the inhibitor nor a lower
concentration (200 ng/ml, which did not substantially affect
growth of the wt strain) suppressed the pam16-I61N (ts) phenotype.
Cell Cycle Analysis of Strains Containing pam16-I61N and
sur4D
The cell cycle profile of wt, pam16-I61N, sur4D and pam16-I61N
sur4D strains was assessed by flow cytometry at 30uC and 34uC to
determine whether the cells arrested at a specific phase (Figure 4).
During normal exponential growth at 30uC in YEPD (Figure 4,
row 1), cell cycle analysis showed that 29% of wt cells were in G1
compared to 42% of pam16-I61N cells. The sur4D and the pam16-
I61N sur4D strains had fewer cells in G1 than the wt and pam16-
I61N strain.
When shifted to the non-permissive temperature of 34uC
(Figure 4, row 2) wt cells continued to replicate with a similar cell
cycle profile at 6 h and 24 h with slightly more cells accumulating in
G1 than at 30uC. In contrast, the majority of pam16-I61N cells
arrested in G1. This G1 arrest phenotype was quantitatively
complete in cells shifted to 37uC (data not shown). The G1 arrest in
pam16-I61N was relieved in the pam16-I61N sur4D strain (Figure 4,
row 3), and correlates with the improved fermentative growth of the
double mutant strain at 34uC (Figure 2C, D, Figure 3).
Strains Containing pam16-I61N and sur4D have Altered
Morphological Features
Wild type, pam16-I61N, sur4D, and pam16-I61N sur4D cells
grown at 32uC were examined by transmission electron micros-
copy (Figure 5 and Figure S4). Cell walls, cell membranes and the
nucleus were similar in all four strains. In contrast, the pam16-I61N
mutant had fewer and smaller mitochondria than wt cells
(Figure 5A, B; horizontal arrows). In addition, the pam16-I61N
strain contained large vesicles with no electron dense material in
the center and thickened walls (small angled arrows). These
structures were less apparent in the wt strain.
The mitochondria of the sur4D strain (Figure 5C) appeared
similar to those in the wt strain. The sur4D strain also contained an
additional feature, a large number of highly electron dense vesicles
(vertical arrows). pam16-I61N sur4D cells (Figure 5D) had improved
mitochondrial morphology and contained smaller vesicles com-
pared to pam16-I61N cells. Similar to sur4D cells, the pam16-I61N
sur4D strain had numerous other vesicles containing highly
Figure 2. Deletion of SUR4 suppresses the fermentative growth
defect of pam16-I61N at 34uC. Effect of temperature on the
proliferation of PAM16 and SUR4 mutant strains was determined with
a Bioscreen incubator. Strains were grown for 48 h at 30uC (A), 32uC (B),
or 34uC (C). Growth curves were generated from the mean values of
optical density readings taken every 30 minutes from triplicate wells.
Wild type (black), pam16-I61N (blue), sur4D (green), and pam16-I61N
sur4D (red). D. Doubling times (h) of yeast strains during log phase
fermentative growth. *pam16-I61N never attains log phase growth at
34uC.
doi:10.1371/journal.pone.0039428.g002
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electron dense material (Figure 5C, D; upward vertical arrows)
that were 10–26 fold more numerous than those present in wt or
pam16-I61N cells. Live cell fluorescent images (Figure S5) of the
strains transformed with a mitochondrial targeted GFP [58] also
showed restoration of elongated mitochondrial morphology in
pam16-I61N sur4D compared to the small fragmented mitochon-
dria of the pam16-I61N strain.
Strains Containing pam16-I61N and sur4D have Altered
Numbers of Peroxisomes
Pex29 and Pex30 are peroxisomal membrane proteins that
control peroxisome size, number, and distribution. The absence of
either of these genes reduced pam16-I61N viability (Figure 1 and
Table 2). The electron microscopy of the two strains deleted in
SUR4 showed abundant electron dense vesicles, which could be
peroxisomes (Figure 5C, D and Figure S4C, D). To determine if
these vesicles were peroxisomes, we performed live cell imaging
using a Pot1-GFP fusion protein. Pot1 is specific marker for
mature functional peroxisomes.
Fluorescence microscopy showed that the wt strain grown in
glucose had few, small peroxisomes (0.6 peroxisomes/cell). The
fluorescence intensity of Pot1-GFP was weak and consistent with
the low protein expression observed on western blot (Figure 6A, F).
Growing wt cells for 4 h in glycerol/ethanol or oleic acid resulted
in an increase in peroxisome number (3.7–4.1 peroxisomes/cell),
increased organelle size, and increased fluorescence intensity as
expected (Figure 6A and E). These changes were not seen in
pam16-I61N. The pam16-I61N strain had approximately twice as
many peroxisomes as wt cells in glucose but exhibited no increase
in peroxisome number or fluorescence intensity following culture
in glycerol/ethanol or oleic acid (Figure 6B, E).
The sur4D and the pam16-I61N sur4D strains had 4.1 and 3.2 fold,
respectively, more peroxisomes than the wt strain grown in glucose
(Figure 6C–E). In glycerol/ethanol or oleic acid containing media,
the number of fluorescent structures increased in sur4D (2.2–2.4
fold) and the pam16-I61N sur4D (1.9 fold in glycerol/ethanol, 1.3
fold in oleic acid). The intensity of Pot1-GFP in the sur4D cells was
higher than those in pam16-I61N sur4D cells. Quantitation of Pot1-
GFP levels by western blot confirmed that the two strains with
pam16-I61N had reduced Pot1 expression (Figure 6F).
Increased peroxisome production in Saccharomyces cerevisiae occurs
in response to changes in carbon source and involves multiple
signaling pathways leading to transcriptional activation of genes
encoding peroxisomal proteins (reviewed in [59,60]). Pot1 expres-
sion is repressed in glucose, derepressed in glycerol/ethanol and
induced in oleic acid containing media [61]. Although sur4D and
pam16-I61N sur4D cells grow well in glucose at 32uC (Figure 3), they
have a higher baseline peroxisome content (Figure 6) suggesting
partial derepression of peroxisomal protein gene transcription.
Since SUR4 deletion results in increased peroxisome content in
glycerol/ethanol or oleate these strains have overcome the block in
peroxisome induction characteristic of the pam16-I61N strain.
Sphingolipid Composition is Altered in the pam16-I61N
Strain
Sphingolipids consist of a long-chain base amide linked to a long
chain fatty acid. They are critical for plasma membrane structure,
Figure 3. Effects of temperature and disruption of sphingolipid synthesis on proliferation. Five fold serial dilutions of wt, pam16-I61N,
sur4D, and pam16-I61N sur4D were grown on YEPD or YEPD with the indicated concentrations of the serine palmitoyltransferase inhibitor (myriocin)
at the temperatures shown. Myriocin (400 ng/ml) impaired the growth of all strains, but neither 200 ng/ml nor 400 ng/ml suppressed the pam16-
I61N (ts) growth phenotype, unlike the specific suppression by sur4D.
doi:10.1371/journal.pone.0039428.g003
Figure 4. G1 cell cycle arrest of pam16-I61N mutant strain at
34uC is relieved by sur4D. Flow cytometry of wt (Y8835), pam16-I61N,
sur4D and pam16-I61N sur4D. Cultures were kept at mid-logarithmic
phase in YEPD at 30uC or shifted to 34uC for 6 or 24 h. Histograms show
the number of cells with G1, S and G2 DNA content as measured by
Sytox Green fluorescence. The mean percentage of G1 cells is indicated
below the G1 peak.
doi:10.1371/journal.pone.0039428.g004
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Figure 5. Effects of pam16-I61N and sur4D on yeast morphology. Yeast strains were examined by transmission electron microscopy. pam16-
I61N (Panel B) had fewer and smaller mitochondria (horizontal arrows) than wt cells (Panel A). pam16-I61N cells had vesicles with thickened walls and
no electron dense material in the center (upward angled arrows). The sur4D mutation restores near normal mitochondrial morphology to the pam16-
I61N strain and increases peroxisome number (upward vertical arrows in Panels C and D)(12,0006magnification; scale bar = 500 nm).
doi:10.1371/journal.pone.0039428.g005
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lipid raft formation, and play important roles in numerous
signaling pathways. The observation that the five suppressors of
pam16-I61N are involved in sphingolipid metabolism suggested
that there could be changes in sphingolipid levels that were
biologically important. To investigate this possibility we measured
the levels of these molecules in each of the four strains by
quantitative mass spectrometry.
Log phase wt, pam16-I61N, sur4D and pam16-I61N sur4D strains
cultured in YEPD (30uC) were then incubated for 6 h at 34uC, a
temperature at which pam16-I61N cells lose the ability to
proliferate, accumulate in G1, and remain fully viable. pam16-
I61N sur4D cells grow at 34uC but with doubling times that are
1.76 longer than wt cells (Figure 2C, D). The levels of the
predominant sphingoid bases, dihydrosphingosine and phyto-
sphingosine, as well as their phosphorylated derivatives were the
same for wt and pam16-I61N cells (Table S1). The highly abundant
C22–26 alpha-hydroxy-phytoceramides and the unsaturated
alpha-hydroxy-phytoceramides were also similar in these two
strains. The initial steps in de novo sphingolipid biosynthesis
therefore appear to be unaffected by the pam16-I61N mutation.
In contrast, the amounts of several other sphingolipids were
different in pam16-I61N cells compared to wt cells. C14 and C16
phytoceramide levels were elevated in pam16-I61N, while C20–
C26 phytoceramides were 3–4 fold less abundant in the pam16-
I61N strain. This suggests that the reduced levels of long chain
phytoceramides were offset by an increase in shorter carbon chain
phytoceramides. The levels of alpha-hydroxy-phytoceramides with
chain lengths from C16 to C20 were increased in the pam16-I61N
mutant compared to wt (Table S1 and Figure 7). Most striking was
the 14 fold higher levels of C18 alpha-hydroxy-phytoceramide
(C18aHP) in the pam16-I61N strain compared to wt (p = 0.043)
(Figure 7).
Next we compared whether the deletion of SUR4 affected
sphingolipid levels in the pam16-I61N strain. pam16-I61N sur4D
resulted in increased levels of many sphingolipids species
compared to pam16-I61N including the sphingolipid bases
dihydrosphingosine and phytosphingosine (Table S1). The phos-
phorylated forms of these bases were even more elevated than the
unphosphorylated forms. pam16-I61N sur4D also exhibited in-
creases in C20:1 and C22 alpha-hydroxy-phytoceramide and low
levels of the very long chain C24 and C26 molecules as expected
with a SUR4 deletion. Many of these changes in sphingolipids were
also observed in the sur4D strain. Importantly, deletion of SUR4,
which by itself had no effect on the level of C18 alpha hydroxy
phytoceramides, suppressed the elevated levels of this metabolite
in the pam16-I61N mutant to essentially the wt level (Table S1 and
Figure 7). C16aHP levels showed a similar trend in these strains
but were not statistically significant.
The dramatic effect of sur4D in suppressing the 14-fold increase
in C18 alpha hydroxy phytoceramides in the pam16-I61N strain
suggested that a similar effect might underlie the suppressor
phenotypes of the other sphingolipid biosynthetic genes. To test
this possibility, we constructed suppressor strains by deleting ISC1,
IPT1, SKN1 and FEN1 in the pam16-I61N strain and performed
sphingolipid profiling as before. C18aHP was 7.5 fold higher in
the pam16-I61N strain compared to wt (Figure S7) and except for
fen1D, the weakest suppressor, the double mutant strains had
C18aHP levels similar to wt cells. These data identify C18aHP as
an important molecule that may underlie the effects we observe in
fermentative growth in the pam16-I61N strain.
Cardiolipin Levels are Decreased in pam16-I61N and
pam16-I61N sur4D
Since phospholipids regulate Isc1 activity [62] and CRD1 and
TAZ1 are SSL with PAM16 (Figure 1, Figure S2, and Table 2) we
measured the major phospholipid content of wt, pam16-I61N, sur4D
and pam16-I61N sur4D strains by thin layer chromatography (Figure
S6). No differences in phosphatidic acid, phosphatidylserine,
phosphatidylcholine, phosphatidylethanolamine or phosphatidyli-
nositol were detected suggesting that they did not contribute to the
growth and morphology characteristics observed in the pam16-I61N
strain at non-permissive temperatures. However, cardiolipin levels in
pam16-I61N were 50% of the wt strain (p,0.05) and were further
reduced in pam16-I61N sur4D to 14% of wt (p,0.01), n=4. Since
cardiolipin levels were further reduced in pam16-I61N by deletion of
SUR4 cardiolipin is not involved in the fermentative growth defect.
Decreased cardiolipin levels have been shown to impair oxidative
phosphorylation [29] suggesting that the loss of respiratory growth
Figure 6. Effects of pam16-I61N and sur4D on peroxisome formation in glucose, glycerol/ethanol and oleic acid containing media.
Live-cell fluorescence microscopy (top frames) and the corresponding differential interference contrast (DIC) image (bottom frames) of wt (A), pam16-
I61N (B), sur4D (C), and pam16-I61N sur4D (D) cells containing GFP-tagged Pot1 to identify peroxisomes. Cultures grown in synthetic media at 30uC
with glucose were then grown at 32uC for an additional 3 h with glucose, glycerol/ethanol or oleic acid as the carbon source. Quantitation of
peroxisomes/cell (E) for each strain grown on the indicated carbon source. Western blot (F) of Pot1-GFP (Mr = 75 kD) and Pgk1 (Mr = 45 kD) in wt,
pam16-I61N, sur4D and pam16-I61N sur4D whole cell lysates (40 mg protein/lane). Pgk1 was used to demonstrate that Pot1 is specifically induced by
media with glycerol/ethanol and oleic acid carbon sources. Numbers indicate the quantitation of band volumes for Pot1-GFP (61025) and Pgk1
(61026) in pixels. BD indicates that the band was below the level of detection.
doi:10.1371/journal.pone.0039428.g006
Figure 7. C18 alpha-hydroxy-phytoceramide levels are elevat-
ed in the pam16-I61N strain compared to wt and are similar to
wt in pam16-I61N sur4D. Overnight yeast cultures of wt, pam16-I61N,
sur4D, and pam16-I61N sur4D strains grown in YEPD at 30uC were
diluted into early log phase and grown for 6 h at 34uC. The mean level
6 SEM (pmole/nmole phosphate) of C18 alpha-hydroxy-phytoceramide
was determined by mass spectrometry. C18 alpha-hydroxy-phytocer-
amide was 12–15 fold higher in the pam16-I61N strain compared to wt,
*p = 0.043, n = 3. The sur4D and pam16-I61N sur4D strains had C18
alpha-hydroxy-phytoceramide levels that were no different than wt
cells.
doi:10.1371/journal.pone.0039428.g007
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Figure 8. Illustration of the synthetic lethal interactions, metabolic pathways and morphological features of pam16-I61N and pam16-
I61N sur4D. (A) pam16-I61N strain. Nuclear, mitochondrial, and peroxisome associated negative genetic interactions leading to a SSL phenotype are
indicated in blue. These interactions demonstrate the importance of Pam16 in mitochondrial protein import, Rpd3L function in the nucleus,
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(at all temperatures) in pam16-I61N sur4D (Figure 2 A–C) may be
mediated by the change in cardiolipin levels.
Discussion
PAM16 Genetic Interactions and Function
To identify biological pathways affected by Magmas, condi-
tional mutants were generated in the yeast ortholog PAM16. The
pam16-I61N mutant strain, which was unable to proliferate on
glucose at 34uC, was used to identify negative synthetic
interactions and to determine the effects of impaired Pam16
function. We found that impaired Pam16 affects growth, cell
morphology, mitochondrial protein import, oxidative metabolism,
fermentation, lipid/sphingolipid metabolism, peroxisome biosyn-
thesis, and histone modification.
Suppressors of pam16-I61N Participate in Sphingolipid
Biosynthesis
To detect additional genes functionally connected to PAM16 we
screened the gene-deletion array to find second site suppressors of
pam16-I61N. Five genes (SUR4, ISC1, IPT1, SKN1 and FEN1) were
identified that when deleted rescued the fermentative but not the
respiratory proliferation defect of the pam16-I61N strain at 34uC.
All of these suppressors are involved in sphingolipid biosynthesis
(Figure 8B) indicating an important role for sphingolipids in the
pam16-I61N phenotype [47,63,64,65]. The lack of pam16-I61N
suppression with myriocin treatment suggests that the reversal of
the pam16-I61N fermentative growth phenotype by deletion of
SUR4, ISC1, IPT1, SKN1 or FEN1 is specific.
sur4D Rescues a Subset of pam16-I61N SSL Interactions
To determine which pam16-I61N SSL interactions could be
compensated by sur4D, the gene-deletion array was queried with
the double mutant (Table 2). Synthetic lethal genes found in the
mitochondrial lipid metabolism and Pfk2, a glycolytic enzyme,
were corrected by the absence of SUR4 demonstrating interde-
pendencies between these pathways (Figure 1 and Table 2). In
contrast, deletions of genes involved in the Rpd3L complex and
the two PEX genes remained synthetic lethal with pam16-I61N
sur4D. Thus, compromised Rpd3L function or compromised
peroxisome biogenesis impedes growth in Pam16 deficient cells by
mechanisms that are distinct from Pfk2 and the mitochondrial
lipid metabolism genes described above.
The deletion of SUR4 results in increased peroxisome biosyn-
thesis and the restoration of fermentative growth in the pam16-
I61N strain. However, deletion of SUR4 is unable to suppress the
slow growth phenotype of pam16-I61N pex29D or pam16-I61N
pex30D. This may reflect a requirement of PEX29 and PEX30 for
the efficient production of peroxisomes, which cannot be bypassed
by deletion of SUR4. Increased peroxisome number in pam16-I61N
sur4D cells may be necessary for maintaining energy production
via beta-oxidation and/or for reducing detrimental reactive
oxygen species that could result from impaired electron transfer
in the oxidative phosphorylation complexes [66].
Biological Features of pam16-I61N and pam16-I61N sur4D
After establishing the importance of the pam16-I61N mutation
and the sur4D suppressor we evaluated the biological effects of
these two mutations in vivo. Significant morphological changes in
the pam16-I61N strain included small mitochondria and enlarged
clear-centered vesicles. Rudimentary mitochondria are a known
consequence of defective mitochondrial protein import [67]
corroborating the importance of Pam16 in this function. The
vesicle accumulation seen in pam16-I61N is similar to that
described in several mutants strains with defects in endoplasmic
reticulum to Golgi trafficking of phospholipids and may reflect
altered sphingolipid metabolism in the endoplasmic reticulum
[68]. These large vesicles are similar to those that occur during the
unfolded protein response [69,70,71]. Another feature of pam16-
I61N cells is their failure to induce peroxisomes when grown on
oleate or glycerol/ethanol containing media. This differs from wt
strains which increase peroxisome biogenesis and fatty acid
oxidation when grown on these carbon sources [72].
The absence of Sur4 reversed many of the biological effects seen
in the pam16-I61N strain. pam16-I61N sur4D cells had larger
mitochondria, and fewer large clear vesicles than pam16-I61N.
The improvement in mitochondrial morphology observed with the
deletion of SUR4 in pam16-I61Nmay result from the normalization
of Pam16 function or from the reduced activity of specific inhibitory
sphingolipids (for example, C18aHP). Significantly, pam16-I61N
sur4D recovered the ability to increase peroxisome number and size
when grown in YPGE or oleic acid. The recovery of perixosome
synthesis in the double mutant correlates with the resumption of
fermentative growth. Alleviation of the unfolded protein response
requires lipid biosynthesis in the ER [69] and precursor molecules
required for lipid biosynthesis could be supplied by peroxisomal
degradation of very long chain fatty acids (VLCFA). Thus recovery
from G1 arrest may be due to increased availability of lipid
intermediates and of substrates for energy production.
Elevated C18 Alpha-hydroxy-phytoceramide Levels are
Observed with pam16-I61N
Sphingolipids are incorporated into plasma and organelle
membranes, lipid rafts and cytoplasmic protein complexes. The
sphingolipid content of membranes is known to affect many
cellular processes including endocytosis, exocytosis and actin
cytoskeleton dynamics, calcium signaling, transcription and
translation, cell cycle control, differentiation, stress resistance
and aging (reviewed in [47,63]). In addition to their role in
membrane biology, sphingolipids and their metabolites can act as
intracellular signaling molecules to coordinate nutrition and
energy production through sterol metabolism [73], serine utiliza-
tion, and phospholipid metabolism [74].
The pam16-I61N strain had altered levels of many sphingolipid
metabolites compared to wt cells (Table S1). Some of the changes
in sphingolipid content in pam16-I61N cells were corrected towards
wt levels by the deletion of SUR4. The most dramatic effect
occurred for C18aHP, which had 14 fold higher levels in pam16-
peroxisome biogenesis and energy metabolism. Defects in Pam16 result in rudimentary mitochondria and impaired fermentation and oxidative
phosphorylation. The increase in C18aHP likely results from the Isc1 mediated breakdown of complex sphingolipids. The inability of pam16-I61N to
induce peroxisomes results in decreased beta-oxidation of VLCFA. (B) pam16-I61N sur4D strain. Negative genetic interactions leading to a SSL
phenotype are indicated in blue. Deletion of any one of five genes (red bold font) resulted in a block in the sphingolipid biosynthesis pathway (red
bar) suppressing the fermentative growth defect of pam16-I61N. The pam16-I61N sur4D stain has morphologically restored mitochondria, increased
numbers of inducible peroxisomes and wt levels of C18 alpha-hydroxy-phytoceramide. Metabolic intermediates and complex sphingolipids
synthesized in the endoplasmic reticulum and Golgi are shown in bold font. Green arrows indicate changes up (increased) or down (reduced).
Abbreviations: DHS: dihydrosphingosine; DHSP: dihydrosphingosine-1-phosphate; PHS: phytosphingosine; PHSP: phytosphingosine-1-phosphate;
VLCFA: very long chain fatty acid.
doi:10.1371/journal.pone.0039428.g008
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I61N than in wt strains and were restored to wt levels in pam16-
I61N sur4D (Figure 7 and Figure 8A and B). Since the deletion of
SUR4 also restored fermentative proliferation and most of the
morphological changes resulting from pam16-I61N, C18aHP could
be an important mediator of the effects of this mutation. Studies in
Neurospora crassa also demonstrate the importance of C18aHP. In
this organism heat stress and carbohydrate deprivation specifically
induced C18aHP, which resulted in cell death [75].
Potential Mechanisms by which pam16-I61N Increases
C18aHP Levels During Fermentative Growth
It is unclear whether the dramatic increase in C18aHP levels is
a cause or a consequence of the fermentative growth arrest of
pam16-I61N. However all five suppressor strains reduced the
pam16-I61N induced elevation of C18aHP (Figure S7) suggesting
that increased levels of C18aHP are responsible for the impaired
fermentative growth. The elevated levels of C18aHP observed in
the pam16-I61N strain could result from either increased synthesis
or reduced degradation.
Since Pam16 is required for mitochondrial presequence
translocase activity and C18aHP is enriched in mitochondrial
membranes [50], it is reasonable to consider that pam16-I61N
would result in increased accumulation of C18aHP by reducing its
mitochondrial utilization or degradation. This would require that
C18aHP enter the mitochondria through a translocase dependent
carrier protein. Alternatively pam16-I61N could affect C18aHP
degradation pathways instead of its mitochondrial uptake.
However neither of these possibilities is consistent with the 5
deletion gene suppressor results.
Instead our data is most consistent with the hypothesis that
elevated C18aHP in pam16-I61N is predominantly a result of its
increased synthesis from complex sphingolipids and not from the
de novo synthesis pathway (Figure 8). Deletion of SCS7, a gene
required for de novo synthesis of alpha-hydroxy-phytoceramides
[76], did not suppress the pam16-I61N slow growth phenotype
(data not shown). This implies that the accumulation of C18aHP
results from increased degradation of complex sphingolipids and
the lower levels in suppressed strains results from reduced
degradation of complex sphingolipids.
Deletion of ISC1 results in decreased cellular C18aHP levels
[50]. The most abundant Isc1 substrates in wt strains are those
sphingolipids with C26 very long chain fatty acids (VLCFA) that
are synthesized by Sur4, and the most abundant Isc1 product is
C26 alpha-hydroxy-phytoceramide [50]. The pam16-I61N sur4D
strain may have less C18aHP because C26 VLCFAs are not made
in sur4D strains and short chain ceramides are used by the cell in
place of ceramides that contain VLCFAs.
Our data suggests that pam16-I61N induced elevation of
C18aHP is independent of the known mitochondrial activities of
Pam16. The growth arrest phenotype of pam16-I61N and its
reversal in pam16-I61N sur4D still occurs in the respective rho0
strains lacking functional mitochondria. Pam16 may regulate
production of C18aHP by Isc1. The quantitative distribution of
Isc1 in microenvironments within the cytoplasm is uncertain
although much of its activity occurs in the endoplasmic reticulum
during early growth and in the mitochondria after the diauxic shift
[49,50,77]. Pam16 may regulate Isc1 production of C18aHPs that
are typically enriched in the mitochondrial membrane [50].
However the Isc1 preferred substrates, C26 ceramides, are located
primarily in the plasma membrane [47]. Neutral sphingomyelin-
ase 2 (nSMase2) the mammalian homolog of Isc1 localizes to the
plasma membrane and can functionally replace the yeast gene
[78]. It is possible that Isc1 may degrade ceramides at the plasma
membrane during fermentative growth. Since Magmas is present
in extra mitochondrial locations in the cytoplasm [1], there could
be direct interaction between Magmas and SMase2 and their
respective counterparts in yeast in the cytoplasm.
The Inhibitory Effects of Pam16-I61N on Respiratory
Growth are Independent of its Effect on Fermentative
Growth
The Pam16 mutant strain was unable to sustain respiratory
growth at the non-permissive temperature (Figure S1 and Figure 2).
Unlike fermentative growth, deletion of genes involved in sphingo-
lipid synthesis (SUR4, ISC1, IPT1, SKN1 and FEN1) did not correct
the respiratory growth defect (Figure 2 and data not shown). pam16-
I61N resulted in reduced cardiolipin levels and mitochondrial
dysfunction consistent with the severe compromises in mitochon-
drial morphology (Figure 5 and S5). Decreased levels of cardiolipin
have been shown to specifically impair respiratory super complex
formation and cytochrome oxidase activity [32,79,80].
Studies on Blp the Drosophila homolog of Pam16, are consistent
with the findings observed in Saccharomyces cerevisiae during
respiratory growth. Drosophila S2 cells depleted of Blp by RNAi
caused mitochondrial membrane depolarization, decreased ATP
levels, increased ROS, cell cycle arrest and uncoupling of oxidative
phosphorylation [66]. Blp depletion preferentially inhibited
cytochrome oxidase activity, which preceded the inhibition of
protein import into the mitochondrial matrix. Similarly, a Blp
inhibitor (SMMI: small molecule Magmas inhibitor) [81], reduced
mitochondrial membrane potential and cytochrome oxidase
activity prior to detectable effects on the presequence translocase.
Magmas in Human Malignancy
Our findings in yeast suggest that Magmas may be involved in
human malignancy. Unlike their normal counterparts malignant
cells often use aerobic glycolysis for energy requirements. Aerobic
glycolysis results in alterations in the levels of many cellular
metabolites some of which are involved in the pathogenesis of
cancer (reviewed in [82,83]). Since Pam16 has significant effects
on both respiration and fermentation it is likely that Magmas
contributes to the metabolic alterations leading to the initiation
and maintenance of the malignant phenotype.
Materials and Methods
Yeast Strains and Media
Strains used in this study are listed in Table 1. rho0 derivatives
were isolated from parental strains by two rounds of growth to
saturation in minimal medium containing 2% glucose plus 25 mg/
ml ethidium bromide [84], followed by isolation of single colonies
on YEPD and testing for no growth on YPGE. Suppressor strains
were generated in a pam16-I61N mutant background by one-step
replacement of each suppressor gene by a hygromycin resistance
cassette and selection on YEPD plates with 200 mg/ml hygro-
mycin B (Invitrogen, Carlsbad, CA). Yeast were grown in Yeast
Extract and Peptone plus adenine medium with 2% glucose
(YEPD) or 2% glycerol and ethanol (YPGE) on agar plates or in
liquid culture. Synthetic genetic array experiments used yeast
nitrogen base (Becton, Dickinson and Co. Sparks, MD) with added
specific amino acid drop out selection and nourseothricin
(cloNAT; WERNER BioAgents, Germany), canavanine, thialy-
sine, and G418 (Sigma, St. Louis, MO) for serial selection
procedures. In the experiments involving peroxisome analysis the
growth medium was yeast nitrogen base plus amino acids and 2%
glucose, glycerol and ethanol, or 0.25% oleic acid and 0.3%
Brij35. YEPD supplemented with myriocin (Sigma) at the
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indicated concentrations was used in the serine palmitoyltransfer-
ase inhibition experiments.
PAM16 Mutations
PAM16 ts mutants were made by error-prone PCR using yeast
strain W303 [85]. PAM16 cDNA encoding amino acids S41
through D142 was subcloned into pCR-TOPO (Invitrogen) and
used as the template for mutagenesis. The error-prone PCR
products were subcloned into wt PAM16 in pRS315 and
transformed into E. coli XL-1B (Agilent, Santa Clara, CA).
Bacterial colonies were scraped from plates and plasmid DNA was
extracted. W303a haploid yeast containing pam16D::HIS3 and a wt
copy of PAM16 on pRS316 was transformed with the mutant
plasmid library. After eviction of the plasmid by growth at 25uC
on YEPD/FOA [86], surviving colonies were plated on YEPD or
YPGE at 18uC, 30uC, and 37uC to identify ts conditional mutants.
The plasmid DNA was sequenced to determine the mutation
responsible for the conditional phenotype.
Synthetic Genetic Array (SGA)
Query strains were derived from Y7092 (Table 1) with a
nourseothricin resistant gene located adjacent to the chromosomal
pam16-I61N mutant or replacing non-essential genes. The pam16-
I61N sur4D double mutant was derived from the pam16-I61N
query by replacing the SUR4 coding region with URA3. The array
of deletion strains has been described by Tong and Boone [87].
Automated construction of double mutants was achieved by
crossing the set of viable gene-deletion mutants with the chosen
query strain. Deletion strains were arrayed on 7 plates at a density
of 1536 colonies per plate with duplicates of each gene-deletion.
Each SGA screen was performed twice using a Singer RoToR
HDA robot (Singer Instruments, Somerset, UK) for all pinning
procedures. Plates were photographed 30 h after the final pinning
step. The growth of double mutant colonies obtained using a
control strain (Y8835) or the PAM16 mutant strain (pam16-I61N)
were compared by visual inspection and by computer-based image
analysis (ColonyImager software) [88]. All synthetic genetic
interactions were validated by random spore analysis [89].
Proliferation Assay
Log phase cultures of selected strains were counted by
hemocytometer, diluted to 56105 cells/ml, and grown in YEPD
in a microtiter plate shaken at high speed at the indicated
temperature for 48 h in a Bioscreen C MBR (Growth Curves
USA, Piscataway, NJ). Growth curves were derived from OD
600 nm readings of triplicate culture samples measured every 30
minutes. Standard deviations were less than 0.1% of each mean
value. Doubling times were calculated from the slope of the
natural log OD 600 nm vs. time at cell concentrations between
OD 0.2–0.6. Two independent experiments were performed.
Flow Cytometry
Cell cycle and cell size were analyzed by fluorescence activated
cell sorting on a LSRII analyzer (Becton Dickinson, Franklin
Lakes, NJ) at the Albert Einstein College of Medicine Flow
Cytometry Core Facility. Log phase cultures of yeast strains grown
in YEPD at 30uC were switched to 34uC for the times indicated,
washed in buffer and fixed in 70% ethanol/H2O. Fixed cells were
digested with RNAse A and proteinase K (Sigma) and stained with
Sytox green (Invitrogen). Cells were sonicated for 5 seconds at
30% power with a Sonic Dismembrator Model 500 (GE
Healthcare, Piscataway, NJ) prior to analysis. Quantitation of
percent cells in cell cycle stages was determined using FloJo
analysis software (BD Biosciences, San Jose, CA). Data shown is
representative of 3 independent experiments.
Electron Microscopy
Cultures of wt, pam16-I61N, sur4D and pam16-I61N sur4D grown
overnight in YEPD at 30uC were split into prewarmed 32uC
YEPD and grown for 4–6 h until OD 600 nm reached 0.500.
9.5 ml of each culture was fixed (2.5% glutaraldehyde in 0.1 M
sodium cacodylate buffer) and postfixed with 1% osmium
tetroxide, followed by 2% uranyl acetate, dehydrated through a
graded series of ethanol and embedded in LX112 resin (LADD
Research Industries, Burlington, VT). Sections were cut on a
Reichert Ultracut UCT, stained with uranyl acetate followed by
lead citrate and viewed on a JEOL 1200EX transmission electron
microscope at 80 kv at the Analytic Imaging Facility at the Albert
Einstein College of Medicine (AIF). At least 100 cells of each strain
were examined. Mitochondria and peroxisomal number and cell
and mitochondrial cross sectional areas were measured for every
cell contained in two low power fields for each strain using ImageJ
1.40 g software (National Institutes of Health, USA). Differences
between strains were determined by comparing the total organelle
area divided by total cell area. Two independent experiments were
performed.
Live Cell Fluorescence Microscopy
Yeast strains carrying C-terminal GFP-tagged Pot1 to identify
peroxisomes were grown overnight in synthetic media supple-
mented with 2% dextrose. After dilution to an OD 600 nm of
,0.3 (to obtain log phase cultures) in synthetic media supple-
mented with 2% dextrose, 2% glycerol and ethanol, or with 0.25%
oleic acid and 0.3% Brig 35 (Sigma), cultures were grown for an
additional 3 h at 32uC. Yeast strains with a plasmid encoding a
mitochondrial leader sequence-GFP fusion protein (pYX232-
mtgfp) [58] were grown overnight in YEPD at 30uC, split into
prewarmed 32uC YEPD and grown for 4 h. Cells were harvested
prior to live-cell fluorescence microscopy by centrifugation at
3000 rpm for 5 minutes and resuspended in their respective
media. Live-cell fluorescence of the strains was monitored using a
fluorescence microscope (Olympus BX61) at the AIF with a 606
numerical aperture 1.46 objective (PlanApo). Fluorescence or
differential interference contrast (DIC) images were captured with
a cooled CCD camera (Cooke Sensicam QE, Cooke Corporation,
Romulus, MI) using IPLab 4.0 software (BD Biosciences). Images
were analyzed with ImageJ software 1.42q (National Institutes of
Health, USA). In the Pot1-GFP experiments the number of
peroxisomes per cell was the average obtained from at least 100
cells. Two independent experiments were performed.
Western Blot
Forty micrograms of total cellular protein from each yeast strain
was solubilized in Laemmli sample buffer and the proteins were
separated by SDS-PAGE. The proteins were transferred to a
nylon membrane (Westran S, Whatman Inc., Sanford ME) in a
TRIS/glycine-20% methanol solution (100 volt-hour) at 14uC.
Membranes were rinsed, blocked, and then incubated with a
monoclonal antibody to GFP (Roche Applied Science, Indianap-
olis, IN). After washing, the membrane was immersed for 1 h with
peroxidase-labeled secondary antibody, washed four times with
buffer containing 50 mM TRIS at pH 7.5/150 mM NaCl/0.1%
Tween 20 (TBST), for 15 minutes each, and developed in luminol
substrate (Immobilon, Millipore, Billerica, MA). The resulting
image was captured with the ImageQuant LAS4000 biomolecular
imager and the signal intensities of specific bands determined using
ImageQuant TL7.0 software (both from GE Healthcare Life
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Sciences, Piscataway, NJ) and expressed as band volumes. Blots
were stripped and reprobed with a monoclonal antibody to yeast
Pgk1 (Invitrogen) Pgk1 is a protein induced by glucose [90].
Sphingolipid Analysis
Yeast strains were grown in liquid culture in YEPD overnight
at 30uC, diluted to 16106 cells/ml, and incubated for 6 h at
34uC in a shaking water bath. Cultures were washed twice in
cold water and snap frozen in liquid nitrogen. Lipids were
quantitatively analyzed at the Lipidomics Analytical Unit of the
Medical University of South Carolina (http://www.musc.edu/
BCMB/lipidomics/index.shtml) using multicomponent LC/MS
analysis or simultaneous ESI/MS/MS analysis on a Thermo
Finnigan TSQ 7000 triple quadrupole mass spectrometer
operating in a multiple reaction monitoring (MRM) positive
ionization mode as described [91]. The quantity of each
sphingolipid was normalized to organic phosphate determina-
tion. The results shown in Table S1 and Figure 7 are the mean
values from three separate experiments. Sphingolipid content is
expressed as pmole sphingolipid/nmole phosphate. Values were
compared using a one-way ANOVA followed by Dunnett’s
multiple comparison test.
Phospholipid Analysis
Relative phospholipid levels were determined according to the
method of Vaden et al. [92]. Yeast strains were grown in YEPD at
32uC containing 10 mCi 32Pi ml
21 at an OD 600 nm of 0.025 and
incubated to an OD of 0.800. Cells were washed in H2O once and
digested with zymolase to form spheroplasts. Phospholipids were
extracted from the spheroplasts and dissolved in 2:1 chloroform/
methanol. Samples were applied to Whatman LK5 silica gel TLC
plates (GE Healthcare) and separated in chloroform/ethanol/
water/triethylamine 30/35/7/35 v/v for 2 h, dried, and run
again in the same solvent system for another 2 h. The signal
intensity of each band was captured on a phosphoimager screen,
and was analyzed using a Fujifilm FLA-7000 Phosphoimager and
ImageQuant software (GE Healthcare). Four independent exper-
iments were performed.
Supporting Information
Figure S1 Growth characteristics of yeast strains. Five
fold serial dilutions of the wt query strain, and pam16-I61N, were
spotted on YEPD or YPGE plates. pam16-I61N displayed temper-
ature sensitive growth inhibition on medium containing glucose or
glycerol/ethanol at 32uC and growth arrest at 34uC and 37uC.
(TIF)
Figure S2 Synthetic lethal partners of Pam16-I61N.
Schematic of genetic network interactions of SSL partners of
Pam-I61N. 46 deletion strains were synthetic sick or lethal when
paired with mutant Pam16. The synthetic lethal partners were
assigned by the Osprey software program [93] into 10 of 17 broad
gene ontology (GO) process categories; including 20 in Cell
Organization and Biogenesis (purple), 14 in Metabolism (blue), 2
in Unknown Function (gray), 2 in Protein Transport (hot pink),
and 1 each in the Stress Response (flesh), Cell Cycle (green), DNA
Metabolism (beige), Protein Amino Acid Phosphorylation (brown),
and Transcription (turquoise). The schematic shows the genes with
their GO category as a colored circle with the lines connecting
them designating a physical or genetic interaction. The genes were
arranged alphabetically in two concentric circles with the inner
circle containing the genes with the most interactions with other
members of the set and those in the outer circle having fewer
interactions. Edge lines between nodes are colored to represent the
experimental system used to determine the association. These are
synthetic lethality (light green), affinity capture (navy blue), dosage
rescue (orange), two-hybrid (aqua) phenotypic enhancement (pea
green), reconstituted complex (rust), biochemical activity (dark
blue). Two genes, YNL198c and YML090W, were open reading
frames in the SGD. YNL198c was deleted from our SSL set as
redundant because it overlaps the opposite DNA strand coding for
GCR2. YML090W was replaced by RPM2, an essential gene on the
opposite DNA strand whose transcription is inhibited but not
destroyed by the YML090W deletion (Table 2).
(TIF)
Figure S3 Strains lacking functional mitochondria have
the same temperature sensitive effects on growth as
their parental strains. Five fold serial dilutions of two
independent rho0 strains derived from wt, pam16-I61N, sur4D,
and pam16-I61N sur4D were spotted on YEPD plates at the
temperatures indicated. pam16-I61N temperature sensitive growth
inhibition at 34uC and 37uC and suppression in pam16-I61N sur4D
occurred in cells lacking functional mitochondria suggesting that
these effects may be mediated elsewhere in the cell. n = 2.
(TIF)
Figure S4 Effects of pam16-I61N and sur4D on yeast
morphology. Transmission electron microscopy of yeast strains
wt (A), pam16-I61N mutant strain (B), sur4D (C), and pam16-I61N
sur4D (D) are shown in a low power field to demonstrate that the
cells depicted in Figure 5 are representative of the entire
population. (5,0006magnification; bar = 1 um).
(TIF)
Figure S5 Effects of pam16-I61N and sur4D on mito-
chondrial morphology. Live-cell fluorescence microscopy of
wt (A), pam16-I61N (B), sur4D (C) and pam16-I61N sur4D (D)
containing mitochondrial leader-GFP to display mitochondrial
morphology at the semi-permissive temperature (32uC) (left panels)
and the corresponding differential interference contrast image are
shown in the right panels. The fragmented mitochondria
morphology observed in pam16-I61N was restored to the wt
elongated reticular mitochondrial morphology in pam16-I61N
sur4D.
(TIF)
Figure S6 Steady state phospholipid levels in wt,
pam16-I61N, sur4D, pam16-I61N sur4D and crd1D.
Phospholipids from wt, pam16-I61N, sur4D, pam16-I61N sur4D
and crd1D strains were analyzed by thin layer chromatography. (A)
Phosphoimage of a representative plate showing the separation of
32P orthophosphate labeled organic extracts from the indicated
strains. { Phospholipids at low levels in sur4D may be CDP-DAG
and LPI/LPC. (B) Quantitation of phospholipids from each strain
expressed as % total (cpm specific phospholipid/cpm total
phospholipid in sample). Values shown are mean 6 SEM. Only
cardiolipin levels were significantly different. Wt vs pam16-I61N,
*p,0.05; wt vs pam16-I61N sur4D, ** p,0.01. Student’s unpaired
two-tail t-test. (n = 4). Quantitation of total phospholipid (PL) cpm
per lane is shown in the lower right panel. Since wt and pam16-
I61N have similar amounts of monovalent phospholipids, these
phospholipids were not responsible for the slow growth phenotype
and morphological changes occurring in pam16-I61N. pam16-I61N
had lower levels of cardiolipin (CL) than wt, and pam16-I61N sur4D
had even more reduced levels. Therefore CL levels do not account
for the suppression of the pam16-I61N fermentative growth defect
by deletion of SUR4 but could be involved in the respiratory
growth defect (Figure 2). Abbreviations: PDME, phosphatidyldi-
methylethanolamine; PA, phosphatidic acid; PE, phosphatidyleth-
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anolamine; PS, phosphatidylserine; PI, phosphatidylinositol; PC,
phosphatidylcholine; LPI/LPC, lysophosphatidylinositol or lyso-
phosphatidic acid; CDP-DAG, cytidine diphosphate diacylgly-
cerol.
(TIF)
Figure S7 Elevated C18 alpha-hydroxy-phytoceramide
levels in pam16-I61N are reduced in pam16-I61N double
mutants that suppressed the ts slow growth phenotype.
The indicated strains were grown to early log phase in YEPD at
30uC before shifting the temperature to 34uC. Cells were
harvested after 6 h at the elevated temperature. The normalized
mean level 6 SEM of C18 alpha-hydroxy-phytoceramide was
determined by mass spectrometry (n = 4). Wt (black), pam16-I61N,
(blue), pam16-I61N sur4D (red), pam16-I61N isc1D (yellow), pam16-
I61N ipt1D (green), pam16-I61N skn1D (purple), pam16-I61N fenD
(orange). C18 alpha-hydroxy-phytoceramide was 7.5 fold higher in
the pam16-I61N strain compared to wt in these experiments.
Except for fen1D, the weakest suppressor, the double mutant
strains had C18 alpha-hydroxy-phytoceramide levels similar to wt.
(TIF)
Table S1 Comparison of sphingolipid content in wild
type, pam16-I61N, sur4D and pam16-I61N sur4D strains.
The sphingolipid content of strains growing in logarithmic phase
at 34uC were measured by mass spectrometry. The quantity of
each sphingolipid was normalized to organic phosphate. The
values shown are the means 6 SEM (pmole sphingolipid/nmole
phosphate). n = 3. Abbreviations: aOH, alpha-hydroxy; Cer,
ceramide; dh, dihydro; Sph, sphingosine; P, phosphate.
(XLSX)
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